{
  "docId": "019de077-60e9-755b-a2a9-f474a1c234cc",
  "docSlug": "c7a8fd91214a0cf2ae7cadcb747376a3",
  "documentTitle": "MindMed | Investor Presentation Deck | 42 slides",
  "authorId": "mindmed",
  "authorName": "MindMed",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 26,
  "pageCount": 42,
  "prevPage": 25,
  "nextPage": 27,
  "slideType": "appendix_methodology",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "Includes study design, randomization, primary endpoint, entry criteria, and secondary endpoints.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-60e9-755b-a2a9-f474a1c234cc/26",
  "deckHref": "/decks/019de077-60e9-755b-a2a9-f474a1c234cc",
  "deckJsonHref": "/decks/019de077-60e9-755b-a2a9-f474a1c234cc.json",
  "deckAnchorHref": "/decks/019de077-60e9-755b-a2a9-f474a1c234cc#slide-26",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.5,
        "x": 0.095,
        "y": 0.25
      },
      "kind": "diagram",
      "text": "Timeline showing screening, dosing, and follow-up weeks -30 to 12",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "07dc9a8c-01da-42e1-af25-5f9ce29bb4f2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.66,
        "y": 0.59
      },
      "kind": "list",
      "text": "Secondary Endpoints: MADRS at Week 12, MADRS at Week 1, CGI-S at Day 2, Time to retreatment / inefficacy",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6b83d693-f271-4735-b8ca-d05c756769bb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.66,
        "y": 0.39
      },
      "kind": "list",
      "text": "Key Entry Criteria: Men and Women, Ages 18-74, Diagnosis of MDD, MADRS >= 26",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "96ba4fe9-4bcc-4155-a9d0-b8c7f540908a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.16,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "Source: Study MM120-310 study documents. Clinical study designs subject to ongoing regulatory discussion and review, including of Phase 3 clinical trial protocols.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "51c8c7dd-cbad-476a-a178-dfd9c5772b20",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.55,
        "x": 0.038,
        "y": 0.048
      },
      "kind": "title",
      "text": "Phase 3 MDD Trial Schematic: Emerge Study",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "39e014e0-4262-45d2-9f36-e19f92e564aa",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "fc8da65d-bbb2-4da5-9041-cef3acc8b6c8",
      "evidence": "Visual timeline of clinical trial phases",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 28,
      "from": 19,
      "beatId": "1fd2924a-f5db-421b-8be6-577b70c4a187",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Product",
      "beatSlug": "sequoia-pitch-product",
      "evidence": "Slides 19-28 discuss phase 3 study designs and product profile",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}